Gotowa bibliografia na temat „Daunorubicin”
Utwórz poprawne odniesienie w stylach APA, MLA, Chicago, Harvard i wielu innych
Spis treści
Zobacz listy aktualnych artykułów, książek, rozpraw, streszczeń i innych źródeł naukowych na temat „Daunorubicin”.
Przycisk „Dodaj do bibliografii” jest dostępny obok każdej pracy w bibliografii. Użyj go – a my automatycznie utworzymy odniesienie bibliograficzne do wybranej pracy w stylu cytowania, którego potrzebujesz: APA, MLA, Harvard, Chicago, Vancouver itp.
Możesz również pobrać pełny tekst publikacji naukowej w formacie „.pdf” i przeczytać adnotację do pracy online, jeśli odpowiednie parametry są dostępne w metadanych.
Artykuły w czasopismach na temat "Daunorubicin"
Drevin, Guillaume, Marie Briet, Caroline Bazzoli, Emmanuel Gyan, Aline Schmidt, Hervé Dombret, Corentin Orvain i in. "Daunorubicin and Its Active Metabolite Pharmacokinetic Profiles in Acute Myeloid Leukaemia Patients: A Pharmacokinetic Ancillary Study of the BIG-1 Trial". Pharmaceutics 14, nr 4 (5.04.2022): 792. http://dx.doi.org/10.3390/pharmaceutics14040792.
Pełny tekst źródłaZucchetti, Massimo, Amerigo Boiardi, Antonio Silvani, Idria Parisi, Stefano Piccolrovazzi i Maurizio D'Incalci. "Distribution of daunorubicin and daunorubicinol in human glioma tumors after administration of liposomal daunorubicin". Cancer Chemotherapy and Pharmacology 44, nr 2 (17.06.1999): 173–76. http://dx.doi.org/10.1007/s002800050964.
Pełny tekst źródła&NA;. "Daunorubicin see Cytarabine/daunorubicin". Reactions Weekly &NA;, nr 354 (czerwiec 1991): 8. http://dx.doi.org/10.2165/00128415-199103540-00027.
Pełny tekst źródłaCusack, B. J., Stephan P. Young, Robert E. Vestal i Richard D. Olson. "Age-related pharmacokinetics of daunorubicin and daunorubicinol following intravenous bolus daunorubicin administration in the rat". Cancer Chemotherapy and Pharmacology 39, nr 6 (28.02.1997): 505–12. http://dx.doi.org/10.1007/s002800050606.
Pełny tekst źródłaChoi, Min-Koo, Im-Sook Song, Dae-Duk Kim, Suk-Jae Chung i Chang-Koo Shim. "Altered Pharmacokinetics of Daunorubicin in Rats with CCl4-Induced Hepatic Injury". Journal of Pharmacy & Pharmaceutical Sciences 10, nr 4 (16.09.2007): 443. http://dx.doi.org/10.18433/j3mw28.
Pełny tekst źródłaAlbrecht, K. W., S. Leenstra, P. J. M. Bakker, J. H. Beijnen, D. Troost, P. Kaaijk i D. A. Bosch. "High concentration of daunorubicin and daunorubicinol in human malignant astrocytomas after systemic administration of liposomal daunorubicin". Clinical Neurology and Neurosurgery 99 (lipiec 1997): S231. http://dx.doi.org/10.1016/s0303-8467(97)82346-3.
Pełny tekst źródła&NA;. "Daunorubicin". Reactions Weekly &NA;, nr 1184 (styczeń 2008): 15. http://dx.doi.org/10.2165/00128415-200811840-00044.
Pełny tekst źródła&NA;. "Daunorubicin". Reactions Weekly &NA;, nr 562 (sierpień 1995): 6. http://dx.doi.org/10.2165/00128415-199505620-00017.
Pełny tekst źródła&NA;. "Daunorubicin". Reactions Weekly &NA;, nr 392 (marzec 1992): 5. http://dx.doi.org/10.2165/00128415-199203920-00013.
Pełny tekst źródła&NA;. "Daunorubicin". Reactions Weekly &NA;, nr 398 (kwiecień 1992): 6. http://dx.doi.org/10.2165/00128415-199203980-00014.
Pełny tekst źródłaRozprawy doktorskie na temat "Daunorubicin"
Golightly, L. "Trypanosmoma brucei : Studies on the uptake and effects of daunorubicin and daunorubicin carrier preparations". Thesis, University of Sunderland, 1986. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.375648.
Pełny tekst źródłaHardman, Mark Alan. "Design of potential antiprotozoal daunorubicin derivatives". Thesis, De Montfort University, 1985. http://hdl.handle.net/2086/10737.
Pełny tekst źródłaMohammed, Lina Yousif. "Studies on daunorubicin and actinorhodin type II polyketide synthases". Thesis, University of Bristol, 2018. https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.761209.
Pełny tekst źródłaWattana-Amorn, Pakorn. "Studies on the actinorhodin and daunorubicin type II polyketide synthases". Thesis, University of Bristol, 2007. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.441375.
Pełny tekst źródłaBartels, Anna-Maria. "Durchflusszytometrische Untersuchungen zur zellulären Pharmakokinetik von freien und liposomal verkapseltem Daunorubicin". [S.l.] : [s.n.], 2002. http://deposit.ddb.de/cgi-bin/dokserv?idn=965428001.
Pełny tekst źródłaMaharaj, Vanitha. "A vibrational circular dichroism study of deoxyoctanucleotides and their daunorubicin complexes". Thesis, National Library of Canada = Bibliothèque nationale du Canada, 1997. http://www.collectionscanada.ca/obj/s4/f2/dsk3/ftp05/nq20751.pdf.
Pełny tekst źródłaBartels, Anna-Maria. "Durchflußzytometrische Untersuchungen zur zellulären Pharmakokinetik von freien und liposomal verkapseltem Daunorubicin". Doctoral thesis, Humboldt-Universität zu Berlin, Medizinische Fakultät - Universitätsklinikum Charité, 2002. http://dx.doi.org/10.18452/14780.
Pełny tekst źródłaWe studied the cellular pharmacokinetics, including uptake, intracellular distribution and efflux, and the induction of apoptosis as a parameter of pharmacodynamics of the two anthracyclines, free and liposomal encapsulated daunorubicin. We used a flowcytometer and a confocal lasermicroscope to measure the intracellular fluorescence in CEM-cells, corresponding to the intracellular concentration of the drugs. Free daunorubicin invaded initially the cells much quicker than liposomal encapsulated daunorubicin and attained earlier the maximum concentration. After the examined time daunoxome achieved the same maximum concentration as daunorubicin. The invasion of liposomal encapsulated daunorubicin followed a sigmoid course, while free daunorubicin followed a saturation kinetic. It was shown that the uptake of both anthracyclines was time- and concentration-dependent. The examinations about the intracellular distribution showed, that both drugs accumulated in the nucleus after three hours of incubation. Daunorubicin attained quickly the maximum fluorescence there, while daunoxome increased slowly for the next six hours. The results of the apoptosis induction correlated to the results of the uptake experiments. Free daunorubicin induced initially quicker apoptosis than liposomal encapsulated daunorubicin. At the end of the measured time all the apoptosis rates of both drugs appeared to be equal. It was determined that the induction of apoptosis also is time- and concentration-dependent. The efflux of daunoxome was monophasic in contrast to a biphasic decline of daunorubicin. These results indicate that free daunorubicin has improved initial cellular pharmacokinetics and therefore enhanced cytotoxicity compared with liposomal encapsulated daunorubicin. But over the examined period both got equal cytotoxicity. Therefore daunoxome is on the cellular basis at least as effective as daunorubicin.
Battisti, Robert F. "Modifying the sugar moieties of daunorubicin overcomes P-gp-mediated multidrug resistance". Connect to resource, 2007. http://hdl.handle.net/1811/25067.
Pełny tekst źródłaTitle from first page of PDF file. Document formatted into pages: contains 48 p.; also includes graphics. Includes bibliographical references (p. 46-48). Available online via Ohio State University's Knowledge Bank.
Knaust, Eva. "Experimental studies on multidrug resistance in human leukaemia : role of cellular heterogeneity for daunorubicin kinetics /". Linköping : Dept. of Medicine and Care, Univ, 2005. http://www.bibl.liu.se/liupubl/disp/disp2005/med901s.pdf.
Pełny tekst źródłaMasquelier, Michèle. "Leukemia chemotherapy : experimental studies on pharmacological optimisation /". Stockholm, 2004. http://diss.kib.ki.se/2004/91-7140-046-X/.
Pełny tekst źródłaKsiążki na temat "Daunorubicin"
Hardman, Mark Alan. Design of potential antiprotozoal daunorubicin derivatives. Leicester: Leicester Polytechnic, 1985.
Znajdź pełny tekst źródłaCzęści książek na temat "Daunorubicin"
Mader, Ines, Patrizia Fürst-Weger, Robert M. Mader, Elisabeth I. Semenitz, Robert Terkola i Sabine M. Wassertheurer. "Daunorubicin". W Paravasation von Zytostatika, 118–22. Vienna: Springer Vienna, 2002. http://dx.doi.org/10.1007/978-3-7091-3799-4_19.
Pełny tekst źródłaMader, Ines, Patrizia Fürst-Weger, Robert Mader, Elisabeth Nogler-Semenitz i Sabine Wassertheurer. "Daunorubicin". W Extravasation of Cytotoxic Agents, 175–82. Vienna: Springer Vienna, 2010. http://dx.doi.org/10.1007/978-3-211-88893-3_26.
Pełny tekst źródłaMader, Ines, Patrizia E. Fürst-Weger, Robert M. Mader, Elisabeth I. Semenitz, Robert Terkola i Sabine M. Wassertheurer. "Daunorubicin". W Extravasation of Cytotoxic Agents, 107–11. Vienna: Springer Vienna, 2003. http://dx.doi.org/10.1007/978-3-7091-3710-9_19.
Pełny tekst źródłaMader, Ines, Patrizia Fürst-Weger, Robert M. Mader, Elisabeth I. Semenitz, Robert Terkola i Sabine M. Wassertheurer. "Daunorubicin liposomal". W Paravasation von Zytostatika, 123–26. Vienna: Springer Vienna, 2002. http://dx.doi.org/10.1007/978-3-7091-3799-4_20.
Pełny tekst źródłaMader, Ines, Patrizia Fürst-Weger, Robert Mader, Elisabeth Nogler-Semenitz i Sabine Wassertheurer. "Daunorubicin liposomal". W Extravasation of Cytotoxic Agents, 183–86. Vienna: Springer Vienna, 2010. http://dx.doi.org/10.1007/978-3-211-88893-3_27.
Pełny tekst źródłaMader, Ines, Patrizia E. Fürst-Weger, Robert M. Mader, Elisabeth I. Semenitz, Robert Terkola i Sabine M. Wassertheurer. "Daunorubicin liposomal". W Extravasation of Cytotoxic Agents, 112–15. Vienna: Springer Vienna, 2003. http://dx.doi.org/10.1007/978-3-7091-3710-9_20.
Pełny tekst źródłaChaires, Jonathan B. "Molecular Recognition of DNA by Daunorubicin". W ACS Symposium Series, 156–67. Washington, DC: American Chemical Society, 1994. http://dx.doi.org/10.1021/bk-1995-0574.ch010.
Pełny tekst źródłaShrestha, Biplav, Anaya Raj Pokhrel, Sumangala Darsandhari, Prakash Parajuli, Jae Kyung Sohng i Ramesh Prasad Pandey. "Engineering Streptomyces peucetius for Doxorubicin and Daunorubicin Biosynthesis". W Environmental Chemistry for a Sustainable World, 191–209. Cham: Springer International Publishing, 2019. http://dx.doi.org/10.1007/978-3-030-01881-8_7.
Pełny tekst źródłaKnaust, E., A. Gruber, A. Porwit-MacDonald i C. Peterson. "Functional Studies of Daunorubicin Transport in Human Leukemic Cells". W Haematology and Blood Transfusion / Hämatologie und Bluttransfusion, 515–20. Berlin, Heidelberg: Springer Berlin Heidelberg, 1998. http://dx.doi.org/10.1007/978-3-642-71960-8_68.
Pełny tekst źródłaAtaullakhanov, Fazoil I., Elena V. Kulikova i Victor M. Vitvitsky. "Binding of Daunorubicin and Doxorubicin to Erythrocytes Treated with Glutaraldehyde". W Erythrocytes as Drug Carriers in Medicine, 143–48. Boston, MA: Springer US, 1997. http://dx.doi.org/10.1007/978-1-4899-0044-9_19.
Pełny tekst źródłaStreszczenia konferencji na temat "Daunorubicin"
Sheng, Xia, Jean-Hugues Parmentier, Jonathan Tucci, Hua Pei, Omar Cortez-Toledo, Christina Dieli-Conwright, Matthew Oberley i in. "Abstract 2960: Adipocytes sequester and metabolize daunorubicin". W Proceedings: AACR Annual Meeting 2017; April 1-5, 2017; Washington, DC. American Association for Cancer Research, 2017. http://dx.doi.org/10.1158/1538-7445.am2017-2960.
Pełny tekst źródłaRios-Doria, Jonathan, Tara L. Costich, Adam Carie i Kevin Sill. "Abstract 4453: Development of a crosslinked, daunorubicin-loaded micelle with superior pharmacokinetics compared to free daunorubicin and with tunable stability". W Proceedings: AACR 102nd Annual Meeting 2011‐‐ Apr 2‐6, 2011; Orlando, FL. American Association for Cancer Research, 2011. http://dx.doi.org/10.1158/1538-7445.am2011-4453.
Pełny tekst źródłaOsdal, Tereza, Lars P. Jordheim, Mihaela Popa, Lene M. Vikebø, Andre Sulen, Siv Lise Bedringaas, Marit Liland Sandvold i in. "Abstract 3274: Combination of elacytarabine and daunorubicin is significantly more effective than combination of cytarabine and daunorubicin in primary patient xenografts of AML." W Proceedings: AACR 104th Annual Meeting 2013; Apr 6-10, 2013; Washington, DC. American Association for Cancer Research, 2013. http://dx.doi.org/10.1158/1538-7445.am2013-3274.
Pełny tekst źródłaSheng, Xia, Jonathan Tucci, James Behan i Steven D. Mittelman. "Abstract 172: Adipocytes decrease daunorubicin concentration in acute lymphoblastic leukemia cells". W Proceedings: AACR Annual Meeting 2014; April 5-9, 2014; San Diego, CA. American Association for Cancer Research, 2014. http://dx.doi.org/10.1158/1538-7445.am2014-172.
Pełny tekst źródłaParmentier, Jean-Hugues, Christina M. Dieli-Conwright i Steven D. Mittelman. "Abstract 3185: Adipocyte-derived hydrogen peroxide promotes chemoresistance to daunorubicin in leukemia cells". W Proceedings: AACR Annual Meeting 2017; April 1-5, 2017; Washington, DC. American Association for Cancer Research, 2017. http://dx.doi.org/10.1158/1538-7445.am2017-3185.
Pełny tekst źródłaSheng, Xia, Jonathan Tucci i Steven D. Mittelman. "Abstract 1247: Reduction of oxidative stress promotes daunorubicin resistance in acute lymphoblastic leukemia cells". W Proceedings: AACR 106th Annual Meeting 2015; April 18-22, 2015; Philadelphia, PA. American Association for Cancer Research, 2015. http://dx.doi.org/10.1158/1538-7445.am2015-1247.
Pełny tekst źródłaCostich, Tara Lee, Rick Crouse, Adam Carie, Taylor Buley, Tyler Ellis, Lauren Repp, J. Edward Semple, Tomas Vojkovsky, Suzanne Bakewell i Kevin Sill. "Abstract 1317: IT-143: A nanoparticle delivery platform that encapsulates daunorubicin and widens therapeutic window". W Proceedings: AACR 107th Annual Meeting 2016; April 16-20, 2016; New Orleans, LA. American Association for Cancer Research, 2016. http://dx.doi.org/10.1158/1538-7445.am2016-1317.
Pełny tekst źródłaContente, Thais C., Iara F. Kretzer, Durvanei A. Maria, Tathiana Capeto, Ricardo Fock i Raul C. Maranhao. "Abstract 2656: Association of daunorubicin to a lipidic nanoemulsion (NEM-ODNR) - in vivo tumor growth inhibition". W Proceedings: AACR 101st Annual Meeting 2010‐‐ Apr 17‐21, 2010; Washington, DC. American Association for Cancer Research, 2010. http://dx.doi.org/10.1158/1538-7445.am10-2656.
Pełny tekst źródłaLin, Tara L., John M. Perry, Xi He, Gregory Reed, Na Zhang, Scott Weir, Joseph McGuirk i Linheng Li. "Abstract CT103: Low-dose daunorubicin to target leukemia stem cells in newly diagnosed and relapsed/refractory AML". W Proceedings: AACR Annual Meeting 2019; March 29-April 3, 2019; Atlanta, GA. American Association for Cancer Research, 2019. http://dx.doi.org/10.1158/1538-7445.sabcs18-ct103.
Pełny tekst źródłaJelinkova, Ludmila, i Yuichiro Suzuki. "Effects Of Daunorubicin On Pulmonary Artery Smooth Muscle Cells In Rat Model Of Hypoxia-Induced Pulmonary Hypertension". W American Thoracic Society 2010 International Conference, May 14-19, 2010 • New Orleans. American Thoracic Society, 2010. http://dx.doi.org/10.1164/ajrccm-conference.2010.181.1_meetingabstracts.a1181.
Pełny tekst źródła